{"id":"NCT00080301","sponsor":"R-Pharm","briefTitle":"Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer","officialTitle":"A Phase III Trial of Novel Epothilone BMS-247550 Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With or Resistant to an Anthracycline and Who Are Taxane Resistant","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-09","primaryCompletion":"2006-11","completion":"2008-03","firstPosted":"2004-03-30","resultsPosted":"2009-08-17","lastUpdate":"2020-11-02"},"enrollment":752,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer","Metastases"],"interventions":[{"type":"DRUG","name":"Ixabepilone + Capecitabine","otherNames":["BMS-247550","IXEMPRA","Epothilone"]},{"type":"DRUG","name":"Capecitabine","otherNames":[]}],"arms":[{"label":"A","type":"EXPERIMENTAL"},{"label":"B","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this clinical research study is to learn if BMS-247550 added to the approved therapy of capecitabine is better than capecitabine alone in shrinking or slowing the growth of the cancer in women with metastatic breast cancer who are resistant to taxane and received anthracycline chemotherapy. The safety of this treatment will also be studied.","primaryOutcome":{"measure":"Progression-free Survival (PFS) Per Independent Radiology Review Committee (IRRC)","timeFrame":"based on assessments every 6 weeks while on treatment until documented disease progression/unacceptable toxicity","effectByArm":[{"arm":"Ixabepilone + Capecitabine","deltaMin":5.85,"sd":null},{"arm":"Capecitabine","deltaMin":4.17,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":".0003"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":127,"countries":["United States","Argentina","Belgium","Brazil","Canada","China","France","Germany","Greece","Hungary","Italy","Malaysia","Mexico","Peru","Philippines","Poland","South Korea","Spain","Sweden","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["17968020","24472478","21937232","21128114"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":127,"n":368},"commonTop":["PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME","NAUSEA","DIARRHOEA","VOMITING","FATIGUE"]}}